Health-e Law Episode 26, Part 2 | AI Adoption in Healthcare: Opportunities, Risks and the Future of Care Delivery
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 278: Equipping Health Systems with the Right AI Solutions with Dr. Mark Sendak of Vega Health
Episode 420 -- DOJ Announces New West Coast Health Care Fraud Strike Force
Hospice Insights Podcast - Bottom Line, Top of Mind: Compliance Checklists for Hospice and Home Health
Health-e Law Podcast, Episode 26 Pt. 1 | AI Adoption in Healthcare: Managing Data Privacy, Vendor Relationships and Governance
False Claims Act Insights - Managed Care FCA Enforcement: Risk Adjustment, AI, Kickbacks, and More
Podcast — Drug Pricing and Market Access: CMS Update With Rujul Desai
Podcast — Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 277: M&A Trends and Growth in the Life Sciences Industry with John Erwin of Maynard Nexsen
Patients Recording Medical Visits: What Health Care Providers Need to Know
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
Podcast - The New Rules of Healthcare Fraud Enforcement
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Strategic Alignment With Collaboration Is Essential to a Life Sciences M&A Exit — Troutman Pepper Locke Podcast
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Charting a Course for Collections: Diagnosing Compliance and Privacy Risks in Medical Debt — The Consumer Finance Podcast
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
Health+Tech - Healthcare Private Equity Conference Recap
Health+Tech - From Software to Scrutiny: Navigating FDA Inspections Under the New QMSR
Health+Tech - The Perfect Storm: Cyber Threats, Regulation and AI in Healthcare
The U.S. Department of Labor issued a new FLSA opinion letter on May 28, 2026, addressing a practical staffing question for hospitals and other employers: Can an exempt employee perform additional hourly, non-exempt work for...more
Summary - For the first time, the U.S. Environmental Protection Agency (EPA) has formally designated pharmaceuticals as a priority drinking water contaminant group under the draft Sixth Contaminant Candidate List (CCL 6)....more
Over the past year, there have been some impressive medical malpractice verdicts throughout the country. Juries remain willing to recognize that patients and their families have suffered significant harm due to healthcare...more
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....more
As health care leaders from across Michigan prepare to gather on Mackinac Island later this month, there is no shortage of issues competing for their attention. Reimbursement pressures continue to challenge financial...more
On June 5, Lupin announced that the U.S. Food and Drug Administration (“FDA”) approved RANLUSPEC, a ranibizumab biosimilar to Genentech’s LUCENTIS®. ...more
Here are curated AG and federal regulatory news stories highlighting key areas in which state and federal regulators’ decisions are having an impact across the US: • AG James Multistate Coalition Secures $36.5 Million...more
On June 3, 2026, CMS published an interim final rule with comment period (the “Rule”) implementing a new Medicaid work and community engagement requirement. This Rule carries out a provision in the One Big Beautiful Bill Act...more
In a unanimous decision of June 4, 2026 in Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc., authored by Justice Jackson, the Supreme Court clarified the pleading requirements for claims of induced patent...more
In the recent ruling in Hikma Pharmaceuticals v. Amarin Pharma, No. 24–889., the U.S. Supreme Court applied its pleading standards established in the Twombly and Iqbal line of cases and unanimously held plaintiff, Amarin...more
On May 27, 2026, Assistant Attorney General Brett A. Shumate issued a memorandum to attorneys in the Commercial Litigation Branch’s Fraud Section and to Assistant United States Attorneys handling FCA cases that may materially...more
The U.S. Departments of Health and Human Services, Labor, and Treasury (the "Departments") and the Office of Personnel Management released a Final Rule on May 28, 2026, significantly restructuring the Federal Independent...more
The Department of Justice (DOJ) is sharply accelerating its review of benefits-fraud qui tam cases. Our White Collar, Government & Internal Investigations and Health Care teams investigate how a new memorandum signals faster...more
Medicaid is an essential source of health coverage for millions of Americans, but it is also widely misunderstood. Misconceptions about who qualifies, what services are covered, and how Medicaid affects personal assets can...more
This week, I was pleased to welcome back to the studio Dana S. Lateulere, Regulatory Consultant with B&C and its consulting affiliate, The Acta Group (Acta®), and James V. Aidala, Senior Government Affairs Consultant at B&C...more
The Illinois Family Neonatal Intensive Care Leave Act took effect June 1, 2026, and provides eligible employees with up to 20 days of unpaid, job-protected leave while a child of an employee is a patient in a neonatal...more
A new lawsuit filed in the U.S. District Court for the District of Columbia tees up a potentially significant challenge to FDA's approach to health claims for dietary supplements and conventional foods....more
Part 3 of our 2025 New Jersey Regulatory Update highlights additional recently adopted rules and amendments impacting healthcare providers, long-term care facilities, residential operators, and licensed professionals. These...more
It is not every day that an 83-page qui tam complaint alleging Stark Law and Anti-Kickback Statute (AKS) violations is dismissed at the pleading stage, particularly when filed by experienced relator’s counsel and accompanied...more
The State Legislature is considering legislation that would extend skilled workforce, prevailing wage, and labor reporting requirements to privately owned facilities used for pharmaceutical research, development, or...more
For many hospitals, off-campus provider-based facilities have long served as a vehicle for expanding access to care, achieving operational and clinical integration of services, and supporting eligibility for programs such as...more
The pharmaceutical industry has been watching Hikma Pharmaceutical USA Inc. v. Amarin Pharma, Inc. (No. 24-889) closely for its potentially sweeping implications for generic drug competition, as discussed in our prior posts –...more
On June 2, the US Food and Drug Administration (FDA) released a new draft guidance called “Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing.”...more
New York AG Letitia James has joined a bipartisan coalition of 36 AGs, and the United States Department of Justice (DOJ) has secured a $36.5 million settlement from CVS Pharmacy Inc (CVS) for fraudulently overbilling Medicaid...more
The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would significantly limit Medicaid managed care State Directed Payments (SDPs) and certain fee-for-service payments. These changes seek to...more
